Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.
Andrew J K OstorFilip Van den BoschKim A PappCecilia AsnalRicardo Blanco-AlonsoJacob AelionKyle CarterVassilis StakiasRalph LippeLeonidas DrogarisAhmed M SolimanMichael M ChenByron PadillaAlan J KivitzPublished in: Rheumatology and therapy (2024)
ClinicalTrials.gov NCT03671148.
Keyphrases